AGF Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.52M | Buy |
16,885
+5,402
| +47% | +$2.4M | 0.03% | 235 |
|
|
2025
Q1 | $5.57M | Buy |
11,483
+10,145
| +758% | +$4.92M | 0.03% | 248 |
|
|
2024
Q4 | $539K | Sell |
1,338
-1,347
| -50% | -$542K | ﹤0.01% | 624 |
|
|
2024
Q3 | $1.25M | Buy |
2,685
+1,429
| +114% | +$665K | 0.01% | 547 |
|
|
2024
Q2 | $589K | Sell |
1,256
-2,510
| -67% | -$1.18M | ﹤0.01% | 611 |
|
|
2024
Q1 | $1.57M | Sell |
3,766
-6,832
| -64% | -$2.86M | 0.01% | 520 |
|
|
2023
Q4 | $4.31M | Sell |
10,598
-3,591
| -25% | -$1.46M | 0.03% | 284 |
|
|
2023
Q3 | $4.93M | Sell |
14,189
-55
| -0.4% | -$19.1K | 0.04% | 251 |
|
|
2023
Q2 | $5.01M | Sell |
14,244
-2,108
| -13% | -$742K | 0.04% | 252 |
|
|
2023
Q1 | $5.15M | Buy |
16,352
+13,552
| +484% | +$4.27M | 0.04% | 266 |
|
|
2022
Q4 | $809K | Buy |
+2,800
| New | +$809K | 0.01% | 627 |
|